Circulating Fibroblast Growth Factor-23 Levels Can Predict Rapid Kidney Function Decline in a Healthy Population: A Community-Based Study

Background: Fibroblast growth factor-23 (FGF-23) associates with decreased kidney function in patients with chronic kidney disease (CKD). However, the correlation between circulating FGF-23 levels and the rate of renal function decline in healthy individuals is largely unknown. We aimed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hsing-Yu, Fang, Wei-Ching, Chu, Shao-Chi, Wang, Po-Hsi, Lee, Chin-Chan, Wu, I-Wen, Sun, Chiao-Yin, Hsu, Heng-Jung, Chen, Chun-Yu, Chen, Yung-Chang, Wu, Vin-Cent, Pan, Heng-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856057/
https://www.ncbi.nlm.nih.gov/pubmed/36671416
http://dx.doi.org/10.3390/biom13010031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856057/
https://www.ncbi.nlm.nih.gov/pubmed/36671416
http://dx.doi.org/10.3390/biom13010031

Ejemplares similares